Does the media prefer CNXU or TNDM?

In the previous week, Conexeu Sciences had 8 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 9 mentions for Conexeu Sciences and 1 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 0.88 beat Conexeu Sciences' score of 0.15 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tandem Diabetes Care 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CNXU or PRCT?

In the previous week, Conexeu Sciences had 7 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 9 mentions for Conexeu Sciences and 2 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 0.42 beat Conexeu Sciences' score of 0.15 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PROCEPT BioRobotics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, CNXU or DRTS?

Conexeu Sciences is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A -$0.11 N/A Alpha Tau Medical N/A N/A -$42.63M -$0.67 N/A

Is CNXU or DRTS more profitable?

Conexeu Sciences' return on equity of 0.00% beat Alpha Tau Medical's return on equity. Company Net Margins Return on Equity Return on Assets Conexeu Sciences N/A N/A N/A Alpha Tau Medical N/A -73.23% -52.90%

Does the media prefer CNXU or DRTS?

In the previous week, Conexeu Sciences and Conexeu Sciences both had 9 articles in the media. Alpha Tau Medical's average media sentiment score of 0.47 beat Conexeu Sciences' score of 0.15 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Tau Medical 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CNXU or BVS?

In the previous week, Conexeu Sciences had 8 more articles in the media than Bioventus. MarketBeat recorded 9 mentions for Conexeu Sciences and 1 mentions for Bioventus. Bioventus' average media sentiment score of 1.06 beat Conexeu Sciences' score of 0.15 indicating that Bioventus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bioventus 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CNXU or INMD?

In the previous week, Conexeu Sciences had 7 more articles in the media than InMode. MarketBeat recorded 9 mentions for Conexeu Sciences and 2 mentions for InMode. InMode's average media sentiment score of 0.29 beat Conexeu Sciences' score of 0.15 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Conexeu Sciences (CNXU) Competitors

$9.15 -0.19 (-2.03%)

Closing price 04:00 PM Eastern

Extended Trading

$9.81 +0.66 (+7.21%)

As of 06:15 PM Eastern

Compare

CNXU vs. TNDM, PRCT, DRTS, BVS, and INMD

Should you buy Conexeu Sciences stock or one of its competitors? MarketBeat compares Conexeu Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conexeu Sciences include Tandem Diabetes Care (TNDM), PROCEPT BioRobotics (PRCT), Alpha Tau Medical (DRTS), Bioventus (BVS), and InMode (INMD). These companies are all part of the "medical equipment" industry.

How does Conexeu Sciences compare to Tandem Diabetes Care?

Conexeu Sciences (NASDAQ:CNXU) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

In the previous week, Conexeu Sciences had 8 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 9 mentions for Conexeu Sciences and 1 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 0.88 beat Conexeu Sciences' score of 0.15 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tandem Diabetes Care	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Conexeu Sciences has higher earnings, but lower revenue than Tandem Diabetes Care. Conexeu Sciences is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	-$0.11	N/A
Tandem Diabetes Care	$1.01B	1.14	-$204.71M	-$1.40	N/A

Conexeu Sciences presently has a consensus price target of $20.00, indicating a potential upside of 118.58%. Tandem Diabetes Care has a consensus price target of $28.93, indicating a potential upside of 71.15%. Given Conexeu Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Conexeu Sciences is more favorable than Tandem Diabetes Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.45

Conexeu Sciences has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -9.20%. Conexeu Sciences' return on equity of 0.00% beat Tandem Diabetes Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%

Summary

Conexeu Sciences beats Tandem Diabetes Care on 7 of the 12 factors compared between the two stocks.

How does Conexeu Sciences compare to PROCEPT BioRobotics?

Conexeu Sciences (NASDAQ:CNXU) and PROCEPT BioRobotics (NASDAQ:PRCT) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Conexeu Sciences has higher earnings, but lower revenue than PROCEPT BioRobotics. Conexeu Sciences is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	-$0.11	N/A
PROCEPT BioRobotics	$308.05M	3.24	-$95.57M	-$1.82	N/A

In the previous week, Conexeu Sciences had 7 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 9 mentions for Conexeu Sciences and 2 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 0.42 beat Conexeu Sciences' score of 0.15 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PROCEPT BioRobotics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Conexeu Sciences has a net margin of 0.00% compared to PROCEPT BioRobotics' net margin of -31.82%. Conexeu Sciences' return on equity of 0.00% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
PROCEPT BioRobotics	-31.82%	-27.70%	-20.29%

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 4.0% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Conexeu Sciences currently has a consensus price target of $20.00, suggesting a potential upside of 118.58%. PROCEPT BioRobotics has a consensus price target of $37.27, suggesting a potential upside of 112.38%. Given Conexeu Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Conexeu Sciences is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
PROCEPT BioRobotics	2 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33

Summary

Conexeu Sciences and PROCEPT BioRobotics tied by winning 7 of the 14 factors compared between the two stocks.

How does Conexeu Sciences compare to Alpha Tau Medical?

Conexeu Sciences (NASDAQ:CNXU) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Conexeu Sciences presently has a consensus target price of $20.00, indicating a potential upside of 118.58%. Alpha Tau Medical has a consensus target price of $12.60, indicating a potential downside of 4.83%. Given Conexeu Sciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Conexeu Sciences is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Conexeu Sciences is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	-$0.11	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

In the previous week, Conexeu Sciences and Conexeu Sciences both had 9 articles in the media. Alpha Tau Medical's average media sentiment score of 0.47 beat Conexeu Sciences' score of 0.15 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Tau Medical	2 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Conexeu Sciences' return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Alpha Tau Medical	N/A	-73.23%	-52.90%

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Conexeu Sciences and Alpha Tau Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Conexeu Sciences compare to Bioventus?

Conexeu Sciences (NASDAQ:CNXU) and Bioventus (NASDAQ:BVS) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

62.9% of Bioventus shares are held by institutional investors. 33.5% of Bioventus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Bioventus has higher revenue and earnings than Conexeu Sciences. Conexeu Sciences is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	-$0.11	N/A
Bioventus	$568.09M	1.69	$22.73M	$0.41	28.00

In the previous week, Conexeu Sciences had 8 more articles in the media than Bioventus. MarketBeat recorded 9 mentions for Conexeu Sciences and 1 mentions for Bioventus. Bioventus' average media sentiment score of 1.06 beat Conexeu Sciences' score of 0.15 indicating that Bioventus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bioventus	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bioventus has a net margin of 4.94% compared to Conexeu Sciences' net margin of 0.00%. Bioventus' return on equity of 29.97% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Bioventus	4.94%	29.97%	9.52%

Conexeu Sciences presently has a consensus target price of $20.00, suggesting a potential upside of 118.58%. Bioventus has a consensus target price of $14.75, suggesting a potential upside of 28.48%. Given Conexeu Sciences' higher probable upside, equities research analysts clearly believe Conexeu Sciences is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Bioventus	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

Bioventus beats Conexeu Sciences on 12 of the 14 factors compared between the two stocks.

How does Conexeu Sciences compare to InMode?

Conexeu Sciences (NASDAQ:CNXU) and InMode (NASDAQ:INMD) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Conexeu Sciences currently has a consensus price target of $20.00, suggesting a potential upside of 118.58%. InMode has a consensus price target of $16.00, suggesting a potential upside of 6.03%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Conexeu Sciences is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has higher revenue and earnings than Conexeu Sciences. Conexeu Sciences is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	-$0.11	N/A
InMode	$370.49M	2.34	$93.83M	$1.36	11.10

In the previous week, Conexeu Sciences had 7 more articles in the media than InMode. MarketBeat recorded 9 mentions for Conexeu Sciences and 2 mentions for InMode. InMode's average media sentiment score of 0.29 beat Conexeu Sciences' score of 0.15 indicating that InMode is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	1 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

68.0% of InMode shares are held by institutional investors. 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

InMode has a net margin of 23.27% compared to Conexeu Sciences' net margin of 0.00%. InMode's return on equity of 13.47% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
InMode	23.27%	13.47%	11.95%

Summary

InMode beats Conexeu Sciences on 9 of the 12 factors compared between the two stocks.

Get Conexeu Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNXU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNXU vs. The Competition

Export

Metric	Conexeu Sciences	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$244.84M	$3.02B	$7.54B	$12.29B
Dividend Yield	N/A	N/A	38.38%	9.41%
P/E Ratio	-83.18	20.80	23.67	23.86
Price / Sales	N/A	246.18	128.60	114.49
Price / Cash	N/A	8.89	165.13	60.45
Price / Book	N/A	5.38	12.81	6.10
Net Income	N/A	$23.43M	$120.21M	$331.84M
7 Day Performance	-12.94%	-4.42%	-0.60%	-1.77%
1 Month Performance	-13.27%	-8.38%	-2.02%	-3.03%
1 Year Performance	N/A	0.89%	9.35%	14.20%

Conexeu Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNXU Conexeu Sciences	2.9932 of 5 stars	$9.15 -2.0%	$20.00 +118.6%	N/A	$244.84M	N/A	N/A	4	News Coverage
TNDM Tandem Diabetes Care	2.3496 of 5 stars	$17.08 +4.8%	$28.93 +69.4%	+10.5%	$1.12B	$1.01B	N/A	2,500
PRCT PROCEPT BioRobotics	2.543 of 5 stars	$19.22 +0.1%	$37.27 +93.9%	-69.9%	$1.09B	$308.05M	N/A	430	News Coverage
DRTS Alpha Tau Medical	1.738 of 5 stars	$13.55 +14.1%	$12.60 -7.0%	+326.6%	$1.07B	N/A	N/A	80	Analyst Forecast Gap Down
BVS Bioventus	4.2717 of 5 stars	$12.06 -3.0%	$14.75 +22.3%	+80.6%	$1.04B	$576.30M	29.41	1,200	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNXU) was last updated on 7/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conexeu Sciences (CNXU) Competitors

CNXU vs. TNDM, PRCT, DRTS, BVS, and INMD

How does Conexeu Sciences compare to Tandem Diabetes Care?

Summary

How does Conexeu Sciences compare to PROCEPT BioRobotics?

Summary

How does Conexeu Sciences compare to Alpha Tau Medical?

Summary

How does Conexeu Sciences compare to Bioventus?

Summary

How does Conexeu Sciences compare to InMode?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conexeu Sciences (CNXU) Competitors

CNXU vs. TNDM, PRCT, DRTS, BVS, and INMD

How does Conexeu Sciences compare to Tandem Diabetes Care?

Does the media prefer CNXU or TNDM?

Which has higher earnings and valuation, CNXU or TNDM?

Do analysts recommend CNXU or TNDM?

Is CNXU or TNDM more profitable?

Summary

How does Conexeu Sciences compare to PROCEPT BioRobotics?

Which has higher valuation & earnings, CNXU or PRCT?

Does the media refer more to CNXU or PRCT?

Is CNXU or PRCT more profitable?

Do insiders and institutionals have more ownership in CNXU or PRCT?

Do analysts recommend CNXU or PRCT?

Summary

How does Conexeu Sciences compare to Alpha Tau Medical?

Do analysts recommend CNXU or DRTS?

Which has preferable earnings & valuation, CNXU or DRTS?

Does the media prefer CNXU or DRTS?

Is CNXU or DRTS more profitable?

Do institutionals and insiders believe in CNXU or DRTS?

Summary

How does Conexeu Sciences compare to Bioventus?

Do insiders and institutionals believe in CNXU or BVS?

Which has stronger valuation and earnings, CNXU or BVS?

Does the media refer more to CNXU or BVS?

Is CNXU or BVS more profitable?

Do analysts rate CNXU or BVS?

Summary

How does Conexeu Sciences compare to InMode?

Do analysts prefer CNXU or INMD?

Which has stronger valuation and earnings, CNXU or INMD?

Does the media refer more to CNXU or INMD?

Do insiders and institutionals believe in CNXU or INMD?

Is CNXU or INMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools